Compare Stocks → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:BUXXNASDAQ:FINENYSE:JPINASDAQ:MNTL Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBUXXStrive Enhanced Income Short Maturity ETF$20.31+0.0%$20.26$20.00▼$21.29$99.52M0.0265,247 shs31,723 shsFINEThemes European Luxury ETF$24.29+0.2%$24.15$22.57▼$26.34$486K0.75765 shs100 shsJPINuveen Preferred and Income Term Fund$19.26-0.1%$19.07$16.25▼$19.36N/AN/A49,225 shs58,600 shsMNTLTema Neuroscience and Mental Health ETF$24.69-0.4%$24.99$23.67▼$26.74$10.86M0.9912,321 shs5,297 shsThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBUXXStrive Enhanced Income Short Maturity ETF+0.05%+0.10%+0.49%+0.49%+2,030,999,900.00%FINEThemes European Luxury ETF+0.16%-0.11%+1.34%-5.58%+2,429,399,900.00%JPINuveen Preferred and Income Term Fund-0.05%-0.21%+2.28%+2.07%+16.02%MNTLTema Neuroscience and Mental Health ETF-0.36%-1.98%+2.88%-6.19%+2,468,999,900.00%The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBUXXStrive Enhanced Income Short Maturity ETFN/AN/AN/AN/AN/AN/AN/AN/AFINEThemes European Luxury ETFN/AN/AN/AN/AN/AN/AN/AN/AJPINuveen Preferred and Income Term FundN/AN/AN/AN/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBUXXStrive Enhanced Income Short Maturity ETFN/AN/AN/AN/AFINEThemes European Luxury ETFN/AN/AN/AN/AJPINuveen Preferred and Income Term FundN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBUXXStrive Enhanced Income Short Maturity ETFN/AN/AN/AN/AN/AN/AFINEThemes European Luxury ETFN/AN/AN/AN/AN/AN/AJPINuveen Preferred and Income Term Fund$-6.09MN/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBUXXStrive Enhanced Income Short Maturity ETFN/AN/A0.00∞N/AN/AN/AN/AN/AFINEThemes European Luxury ETFN/AN/A14.23∞N/AN/AN/AN/AN/AJPINuveen Preferred and Income Term FundN/AN/A0.00∞N/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/A25.24∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBUXXStrive Enhanced Income Short Maturity ETF$0.733.59%N/AN/AN/AFINEThemes European Luxury ETFN/AN/AN/AN/AN/AJPINuveen Preferred and Income Term Fund$1.176.07%-8.10%N/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/AN/ALatest BUXX, JPI, FINE, and MNTL DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2024JPINuveen Preferred and Income Term FundMonthly$0.09806.19%5/14/20245/15/20246/3/20244/1/2024JPINuveen Preferred and Income Term FundMonthly$0.09806.17%4/12/20244/15/20245/1/20243/1/2024JPINuveen Preferred and Income Term FundMonthly$0.09806.24%3/14/20243/15/20244/1/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBUXXStrive Enhanced Income Short Maturity ETFN/AFINEThemes European Luxury ETFN/AJPINuveen Preferred and Income Term FundN/AMNTLTema Neuroscience and Mental Health ETFN/AInsider OwnershipCompanyInsider OwnershipBUXXStrive Enhanced Income Short Maturity ETFN/AFINEThemes European Luxury ETFN/AJPINuveen Preferred and Income Term FundN/AMNTLTema Neuroscience and Mental Health ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBUXXStrive Enhanced Income Short Maturity ETFN/A4.90 millionN/ANot OptionableFINEThemes European Luxury ETFN/A20,000N/AN/AJPINuveen Preferred and Income Term FundN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/A440,000N/AN/ABUXX, JPI, FINE, and MNTL HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeTop HeadlinesSeagate Technology Warns Cloud Demand is Heating Up April 30, 2024 10:10 AMView Seagate Technology Warns Cloud Demand is Heating Up Boston Scientific Bucks the Medtech Slow Down and Raises OutlookApril 30, 2024 10:34 AMView Boston Scientific Bucks the Medtech Slow Down and Raises OutlookNXP Semiconductors Will Set a New High Soon: $300 in SightApril 30, 2024 11:26 AMView NXP Semiconductors Will Set a New High Soon: $300 in SightHilton Demonstrates Asset Light is Right for Investors April 30, 2024 11:08 AMView Hilton Demonstrates Asset Light is Right for Investors Long vs. Short Position: A Breakdown of Stock PositionsMay 22, 2024 9:14 AMView Long vs. Short Position: A Breakdown of Stock PositionsAll HeadlinesCompany DescriptionsStrive Enhanced Income Short Maturity ETFNYSE:BUXXThe Strive Enhanced Income Short Maturity ETF (BUXX) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund is actively managed, investing in a portfolio of various fixed-income securities of any credit rating from issuers all around the globe. The fund aims for a dollar-weighted average maturity of less than two years BUXX was launched on Aug 10, 2023 and is issued by Alpha Architect.Themes European Luxury ETFNASDAQ:FINEThe Themes European Luxury ETF (FINE) is an exchange-traded fund that is based on the Solactive European Luxury index. The fund tracks an index comprised of companies in Developed Europe that offer luxury goods and services. The index selects and weights holdings towards those companies with most business exposure related to the investment theme FINE was launched on Dec 13, 2023 and is issued by Themes.Nuveen Preferred and Income Term FundNYSE:JPINuveen Preferred and Income Term Fund is a close ended balanced mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests into public equity and fixed income markets across the globe. The fund seeks to invest in stocks of companies that are operating in financial services sectors such as bank, insurance, REITs, and utility companies. It primarily invests in preferred securities and other income producing securities including debt securities, hybrid securities, and convertible securities. At least 60% of the fund's assets are rated investment grade i.e. BBB/Baa or better by one of the nationally recognized statistical rating organizations. It employs fundamental and quantitative analysis, with focus a on bottom-up fundamental credit research to create its portfolio. The fund benchmarks the performance of its portfolio against the Bank of America/Merrill Lynch Preferred Stock Fixed Rate Index. Nuveen Preferred and Income Term Fund was founded on July 26, 2012 and is domiciled in the United States.Tema Neuroscience and Mental Health ETFNASDAQ:MNTLThe Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.